| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Recombinant Human IL-13 R alpha 2 Fc Chimera (CHO), CF |
|---|
| Description | Purity >95%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (observed): 75-95 kDa, reducing conditions. MW (theoretical): 64 kDa (monomer). The Recombinant Human IL-13 R alpha 2 Fc Chimera (CHO) from R&D Systems is derived from CHO. The Recombinant Human IL-13 R alpha 2 Fc Chimera (CHO) has been validated for the following applications: Bioactivity. |
|---|
| Size | 100 ug |
|---|
| Concentration | n/a |
|---|
| Applications | Bioactivity |
|---|
| Other Names | cancer/testis antigen 19, CD213a2, CD213a2 antigen, CT19, IL-13 receptor subunit alpha-2, IL13BP, IL13R, IL-13R, IL13R alpha 2, IL-13R subunit alpha-2, IL13RA2, IL-13RA2, IL-13R-alpha-2, interleukin 13 binding protein, interleukin 13 receptor alpha 2 chain, interleukin 13 receptor, alpha 2, interleukin-13 receptor subunit alpha-2, Interleukin-13-binding protein |
|---|
| Gene, Accession, CAS # | IL13RA2, Gene ID: 3598, Accession: NP_000631 |
|---|
| Catalog # | 7147-IR-100 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human IL-13 R alpha 2 Fc Chimera (CHO), CF from R&D SYSTEMS, INC. |
|---|
| Product Specific References | PubMed: 23939024, 24787244 |
|---|
| 產(chǎn)品資料 |
|
|